HOME >> BIOLOGY >> NEWS
Potential new treatment for Gaucher disease developed by scientists at Scripps Research Institute

A group of scientists at The Scripps Research Institute (TSRI) have developed a compound that could potentially be used as a new treatment for Gaucher disease, the most common genetic disorder affecting Jewish people of Eastern European ancestry. Although not tested in humans, the compound has shown great promise in human cell lines cultured from patients who suffer from the disease.

Patients with Gaucher disease may bruise easily due to low blood platelets, and they may have enlargement of the liver and spleen. Sometimes they experience fatigue due to anemia. The disease also causes cells in the bone marrow to become engorged with a fatty storage material, which may lead to bone lesions, weakening the skeleton, and sometimes resulting in painful fractures. In some instances, the disease also impairs the function of the lungs.

In an article that will be published in an upcoming issue of the journal Proceedings of the National Academy of Sciences, the TSRI group describes using small molecules to partially correct the genetic defect that underlies most cases of Gaucher disease. The defect prevents a crucial metabolic enzyme from reaching the location in the cell where it normally functions, but the small molecules act as "chaperones," guiding the mutant enzyme to the right location and allowing it to survive and function.

"This is an entirely new approach to the disease," says TSRI Professor Ernest Beutler, M.D., who is one of the authors of the study and one of the world's leading experts on Gaucher disease and similar metabolic disorders. Beutler's laboratory was the first to clone the gene responsible for Gaucher disease in the mid-1980s.

"And it may be less costly and more convenient than the current treatment," adds Jeffrey W. Kelly, who is the Lita Annenberg Hazen Professor of Chemistry and vice president of academic affairs at TSRI. Kelly led the research effort along with the study's first author, Anu Sawkar, a Ph.D. student in
'"/>

Contact: Jason Bardi
jbardi@scripps.edu
858-784-9254
Scripps Research Institute
4-Nov-2002


Page: 1 2 3 4

Related biology news :

1. Potential for enhanced sequestration of carbon in soils supports evaluations
2. Potential blood test for colon cancer risk
3. Potential cause of arthritis discovered
4. Potential of regenerative medicine explored
5. Potential therapy reported for children, adults with end-stage liver disease
6. Potential allergy vaccine boosts hope for sufferers
7. Potential of tailoring drugs to genetic makeup confirmed--but challenges remain
8. Potential new anthrax therapy discovered
9. Potential gene therapy carriers created that mimic viruses, without the risk
10. New Class Of Synthetic Capsules That Mimic Biological Cells Has Wide Array Of Potential Uses
11. Role Of Protein Linked To Colon Cancer Identified, Offering Potential Target For Therapy

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/11/2019)... WEST LAFAYETTE, Ind. (PRWEB) , ... June 10, 2019 , ... ... Synchrotron Methods” in the July 2019 issue of AAPS PharmSciTech. The article was published ... A. Smith of Improved Pharma, along with Xiaoming Sean Chen of Purdue University. ...
(Date:6/4/2019)... ... June 04, 2019 , ... ... orthopedic medical devices, today announced Q1-19 revenues of $31M, up 12% from Q1-18. ... successful roll-out of strategic investments & operational excellence initiatives worldwide. , Laurent ...
(Date:6/4/2019)... ... 2019 , ... Lajollacooks4u is delighted to announce it has been named as ... is given only to businesses that have achieved consistently outstanding traveler reviews on TripAdvisor, ... , To qualify for the Certificate of Excellence –- an award that only 10 ...
Breaking Biology News(10 mins):
(Date:6/11/2019)... (PRWEB) , ... June 11, 2019 , ... ... of Personalized Stem Cells Inc. (PSC) , has announced that their GMP ... Health, Food and Drug Branch for manufacturing. This is an important milestone ...
(Date:6/6/2019)... ... June 05, 2019 , ... WCCT Global, Inc ., a full-service ... today that they will be receiving 3 awards at the 2019 CRO Leadership Awards, ... awards in the categories of overall Quality and Compatibility (Access to desired markets, cultural ...
(Date:5/31/2019)... Redwood City, California (PRWEB) , ... ... ... received allowance of our patent applications from the USPTO providing proprietary interest ... SYSTEM AND METHOD FOR SLEEP DISORDER DIAGNOSIS AND TREATMENT… extends Somnology’s IP ...
(Date:5/31/2019)... NEWPORT BEACH, Calif. (PRWEB) , ... May 30, ... ... the future of neurotoxins, is pleased to announce the strategic acquisition of Metabiologics, ... for research. The acquisition provides Object exclusive ownership and commercialization rights to a ...
Breaking Biology Technology:
Cached News: